Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

pT/Caggs-NRASV12 Citations (13)

Originally described in: De novo induction of genetically engineered brain tumors in mice using plasmid DNA.
Wiesner SM, Decker SA, Larson JD, Ericson K, Forster C, Gallardo JL, Long C, Demorest ZL, Zamora EA, Low WC, SantaCruz K, Largaespada DA, Ohlfest JR Cancer Res. 2009 Jan 15. 69(2):431-9.
PubMed Journal

Articles Citing pT/Caggs-NRASV12

CRISPR/Cas9-based Pten knock-out and Sleeping Beauty Transposon-mediated Nras knock-in induces hepatocellular carcinoma and hepatic lipid accumulation in mice. Gao M, Liu D. Cancer Biol Ther. 2017 May 17:1-8. doi: 10.1080/15384047.2017.1323597. PubMed
Integration of Oncogenes via Sleeping Beauty as a Mouse Model of HPV16(+) Oral Tumors and Immunologic Control. Lin YH, Yang MC, Tseng SH, Jiang R, Yang A, Farmer E, Peng S, Henkle T, Chang YN, Hung CF, Wu TC. Cancer Immunol Res. 2018 Mar;6(3):305-319. doi: 10.1158/2326-6066.CIR-16-0358. Epub 2018 Jan 23. PubMed
A novel spontaneous hepatocellular carcinoma mouse model for studying T-cell exhaustion in the tumor microenvironment. Liu YT, Tseng TC, Soong RS, Peng CY, Cheng YH, Huang SF, Chuang TH, Kao JH, Huang LR. J Immunother Cancer. 2018 Dec 7;6(1):144. doi: 10.1186/s40425-018-0462-3. PubMed
A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS. McMahon M, Contreras A, Holm M, Uechi T, Forester CM, Pang X, Jackson C, Calvert ME, Chen B, Quigley DA, Luk JM, Kelley RK, Gordan JD, Gill RM, Blanchard SC, Ruggero D. Elife. 2019 Sep 3;8. pii: 48847. doi: 10.7554/eLife.48847. PubMed
Genetically Engineered Mouse Model of Brainstem High-Grade Glioma. Nunez FM, Gauss JC, Mendez FM, Haase S, Lowenstein PR, Castro MG. STAR Protoc. 2020 Nov 25;1(3):100165. doi: 10.1016/j.xpro.2020.100165. eCollection 2020 Dec 18. PubMed
WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression. Wu M, Xia X, Hu J, Fowlkes NW, Li S. Nat Commun. 2021 Jun 9;12(1):3500. doi: 10.1038/s41467-021-23864-9. PubMed
Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine. Tseng SH, Liu L, Peng S, Kim J, Ferrall L, Hung CF, Wu T-. J Biomed Sci. 2021 Sep 13;28(1):63. doi: 10.1186/s12929-021-00759-x. PubMed
METTL1 promotes hepatocarcinogenesis via m(7) G tRNA modification-dependent translation control. Chen Z, Zhu W, Zhu S, Sun K, Liao J, Liu H, Dai Z, Han H, Ren X, Yang Q, Zheng S, Peng B, Peng S, Kuang M, Lin S. Clin Transl Med. 2021 Dec;11(12):e661. doi: 10.1002/ctm2.661. PubMed
JCI20679 suppresses the proliferation of glioblastoma stem cells by activating AMPK and decreasing NFATc2 expression levels. Ando S, Kojima N, Moyama C, Fujita M, Ohta K, Ii H, Nakata S. Mol Med Rep. 2022 Jul;26(1). pii: 238. doi: 10.3892/mmr.2022.12754. Epub 2022 May 27. PubMed
Novel Paired Cell Lines for the Study of Lipid Metabolism and Cancer Stemness of Hepatocellular Carcinoma. Cheng YH, Ko YC, Ku HJ, Huang CC, Yao YC, Liao YT, Chen YT, Huang SF, Huang LR. Front Cell Dev Biol. 2022 May 26;10:821224. doi: 10.3389/fcell.2022.821224. eCollection 2022. PubMed
N(6)-methyladenosine (m(6)A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation. Peng H, Chen B, Wei W, Guo S, Han H, Yang C, Ma J, Wang L, Peng S, Kuang M, Lin S. Nat Metab. 2022 Aug;4(8):1041-1054. doi: 10.1038/s42255-022-00622-9. Epub 2022 Aug 23. PubMed
H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models. Haase S, Banerjee K, Mujeeb AA, Hartlage CS, Nunez FM, Nunez FJ, Alghamri MS, Kadiyala P, Carney S, Barissi MN, Taher AW, Brumley EK, Thompson S, Dreyer JT, Alindogan CT, Garcia-Fabiani MB, Comba A, Venneti S, Ravikumar V, Koschmann C, Carcaboso AM, Vinci M, Rao A, Yu JS, Lowenstein PR, Castro MG. J Clin Invest. 2022 Nov 15;132(22):e154229. doi: 10.1172/JCI154229. PubMed
Targeting the Phosphatidylserine-Immune Checkpoint with a Small-Molecule Maytansinoid Conjugate. Lo CF, Chiu TY, Liu YT, Pan PY, Liu KL, Hsu CY, Fang MY, Huang YC, Yeh TK, Hsu TA, Chen CT, Huang LR, Tsou LK. J Med Chem. 2022 Oct 13;65(19):12802-12824. doi: 10.1021/acs.jmedchem.2c00631. Epub 2022 Sep 26. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.